Evidence map›Paper›PMID 30388364›Full record

ArticleBiochemistry2018

Dynamics and Molecular Mechanisms of p53 Transcriptional Activation.

Tavina L Offutt, Pek U Ieong, Özlem Demir, Rommie E Amaro

Abstract read
In one paragraph

Article in Biochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. LFPM inhibition of RING1-mediated p53Cell death and differentiation · 2026
    Article
  2. TowardsbioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. An integrated view of p53 dynamics, function, and reactivation.Current opinion in structural biology · 2021
    Review
  8. Zinc oxide nanoparticles enhance expression of maspin in human breast cancer cells.Environmental science and pollution research international · 2020
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tavina L OffuttDepartment of Chemistry and Biochemistry , University of California, San Diego , 9500 Gilman Drive , La Jolla , California 92092-0340 , United States.
Pek U IeongDepartment of Chemistry and Biochemistry , University of California, San Diego , 9500 Gilman Drive , La Jolla , California 92092-0340 , United States.
Özlem DemirDepartment of Chemistry and Biochemistry , University of California, San Diego , 9500 Gilman Drive , La Jolla , California 92092-0340 , United States.ORCID 0000-0002-3317-4731
Rommie E AmaroDepartment of Chemistry and Biochemistry , University of California, San Diego , 9500 Gilman Drive , La Jolla , California 92092-0340 , United States.ORCID 0000-0002-9275-9553

Funding

National Biomedical Computation Resource - Competitive Revision SupplementP41GM103426 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AMARO, ROMMIE E · 2012 to 2019
$14.0M
A Structural Systems Biology Approach to Drug DiscoveryDP2OD007237 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AMARO, ROMMIE E · 2010 to 2015
$2.9M
NIGMS NIH HHS P41 GM103426NIH HHS DP2 OD007237
6 · The paper itself

Abstract

The "guardian of the genome", p53, functions as a tumor suppressor that responds to cell stressors such as DNA damage, hypoxia, and tumor formation by inducing cell-cycle arrest, senescence, or apoptosis. Mutation of p53 disrupts its tumor suppressor function, leading to various types of human cancers. One particular mutant, R175H, is a structural mutant that inactivates the DNA damage response pathway and acquires oncogenic functions that promotes both cancer and drug resistance. Our current work aims to understand how p53 wild-type function is disrupted due to the R175H mutation. We use a series of atomistic integrative models built previously from crystal structures of the full-length p53 tetramer bound to DNA and model the R175H mutant using in silico site-directed mutagenesis. Explicitly solvated all-atom molecular dynamics (MD) simulations on wild-type and the R175H mutant p53 reveal insights into how wild-type p53 searches and recognizes DNA, and how this mechanism is disrupted as a result of the R175H mutation. Specifically, our work reveals the optimal quaternary DNA binding mode of the DNA binding domain and shows how this binding mode is altered via symmetry loss as a result of the R175H mutation, indicating a recognition mechanism that is reminiscent of the asymmetry seen in wild type p53 binding to nonspecific genomic elements. Altogether our work sheds new light into the hitherto unseen molecular mechanisms governing transcription factor, DNA recognition.

Indexed as

Molecular Dynamics SimulationProtein MultimerizationTranscriptional ActivationBinding SitesDNAHumansMutationProtein BindingResponse ElementsTumor Suppressor Protein p53DNATP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID30388364
PMCPMC7560988

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.